Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

作者:Larsen Jeremy T; Shanafelt Tait D; Leis Jose F; LaPlant Betsy; Call Tim; Pettinger Adam; Hanson Curtis; Erlichman Charles; Habermann Thomas Matthew; Reeder Craig; Nikcevich Daniel; Bowen Deborah; Conte Michael; Boysen Justin; Secreto Charla; Lesnick Connie; Tschumper Renee; Jelinek Diane; Kay Neil E; Ding Wei
来源:American Journal of Hematology, 2017, 92(8): 759-763.
DOI:10.1002/ajh.24762